MXPA03010373A - Moduladores de receptores ampa alostericos naftotiazina positivos. - Google Patents

Moduladores de receptores ampa alostericos naftotiazina positivos.

Info

Publication number
MXPA03010373A
MXPA03010373A MXPA03010373A MXPA03010373A MXPA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A
Authority
MX
Mexico
Prior art keywords
receptor modulators
paarm
naphtothiazine
positive allosteric
ampa receptor
Prior art date
Application number
MXPA03010373A
Other languages
English (en)
Spanish (es)
Inventor
Winter Karin
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA03010373A publication Critical patent/MXPA03010373A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
MXPA03010373A 2001-05-17 2002-05-15 Moduladores de receptores ampa alostericos naftotiazina positivos. MXPA03010373A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (1)

Publication Number Publication Date
MXPA03010373A true MXPA03010373A (es) 2004-03-16

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010373A MXPA03010373A (es) 2001-05-17 2002-05-15 Moduladores de receptores ampa alostericos naftotiazina positivos.

Country Status (26)

Country Link
EP (1) EP1404340A1 (ja)
JP (1) JP2004529980A (ja)
KR (1) KR20040007572A (ja)
CN (1) CN1533278A (ja)
AR (1) AR036332A1 (ja)
BG (1) BG108324A (ja)
BR (1) BR0209796A (ja)
CA (1) CA2449189A1 (ja)
CO (1) CO5550460A2 (ja)
CZ (1) CZ20033112A3 (ja)
DE (1) DE10123952A1 (ja)
EA (1) EA006608B1 (ja)
EC (1) ECSP034852A (ja)
EE (1) EE200300566A (ja)
HR (1) HRP20030933A2 (ja)
HU (1) HUP0401273A3 (ja)
IL (1) IL158642A0 (ja)
MX (1) MXPA03010373A (ja)
NO (1) NO20035088D0 (ja)
NZ (1) NZ530154A (ja)
PL (1) PL364053A1 (ja)
SK (1) SK14222003A3 (ja)
UY (1) UY27290A1 (ja)
WO (1) WO2002100411A1 (ja)
YU (1) YU90403A (ja)
ZA (1) ZA200308466B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039468B2 (en) * 2006-08-31 2011-10-18 The Governors Of The University Of Alberta Method of inhibition of respiratory depression using positive allosteric AMPA receptor modulators
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
US6346526B1 (en) * 1998-06-25 2002-02-12 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NO20035088L (no) 2003-11-14
DE10123952A1 (de) 2002-11-21
YU90403A (sh) 2006-05-25
HUP0401273A3 (en) 2006-11-28
AR036332A1 (es) 2004-09-01
CO5550460A2 (es) 2005-08-31
CN1533278A (zh) 2004-09-29
SK14222003A3 (sk) 2004-05-04
HUP0401273A2 (hu) 2004-10-28
ZA200308466B (en) 2004-05-24
NO20035088D0 (no) 2003-11-14
BR0209796A (pt) 2004-06-01
CA2449189A1 (en) 2002-12-19
WO2002100411A1 (en) 2002-12-19
JP2004529980A (ja) 2004-09-30
NZ530154A (en) 2005-09-30
IL158642A0 (en) 2004-05-12
PL364053A1 (en) 2004-12-13
CZ20033112A3 (en) 2004-03-17
EA200301167A1 (ru) 2004-06-24
HRP20030933A2 (en) 2004-04-30
UY27290A1 (es) 2002-12-31
ECSP034852A (es) 2003-12-24
EE200300566A (et) 2004-02-16
EA006608B1 (ru) 2006-02-24
EP1404340A1 (en) 2004-04-07
KR20040007572A (ko) 2004-01-24
BG108324A (bg) 2004-12-30

Similar Documents

Publication Publication Date Title
DE602004021472D1 (en) Pyrimiidinverbindungen
SE0104140D0 (sv) Novel Compounds
MXPA02012425A (es) Compuestos nuevos.
MXPA05010137A (es) Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
SE0202133D0 (sv) Novel compounds
TW200833670A (en) Novel compounds 569
AU2002239344A1 (en) Pyrazolopyridines
SE0200920D0 (sv) Novel compounds
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
IL185871A0 (en) N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
MXPA05011596A (es) Derivados de amino-propanol como modulador de receptor de esfingosina-1-fosfato.
SE0202539D0 (sv) Compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
TW200738658A (en) Novel compounds
TW200740781A (en) Novel compounds
DE60112330D1 (en) Pyrazolopyridinderivate
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SE0302139D0 (sv) Novel compounds
TW200604197A (en) New compounds
SE0101038D0 (sv) Novel compounds
RS20050649A (en) Antibacterial indolone oxazolidinones,intermediates for their preparation and pharmaceutical compositions containing them
CA2399377A1 (en) New positive allosteric ampa receptor modulators (paarm), processes for preparing them and their use as pharmaceutical compositions
SE0303280D0 (sv) Novel compounds
SE9902551D0 (sv) Novel compounds